Alan Ezekowitz
Director, Fulcrum Therapeutics (United States).
Companies
- Septerna, Inc.Board member Oct 24, 2024 to now1
- Organon & Co.Board member Jun 2, 2021 to now2
- Fulcrum Therapeutics (United States)Board member Jul 17, 2019 to now3
Holdings
Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.
Shares held
- Septerna, Inc. SEPN117,420 shares4$4.3M at $36.66Mar 7, 2025
- Fulcrum Therapeutics (United States) FULC10,927 shares5$40.4K at $3.70Jun 26, 2026
As of each latest filing. The line shows shares held over time.
Recent filings
- Jun 26, 2026Sold 18,000 shares at $3.65 of Fulcrum Therapeutics (United States)5
- Mar 7, 2025Bought 13,319 shares at $6.93 of Septerna, Inc.4
- Mar 6, 2025Bought 41,355 shares at $6.00 of Septerna, Inc.6
- Mar 5, 2025Bought 37,835 shares at $5.82 of Septerna, Inc.6
- Mar 4, 2025Bought 7,491 shares at $6.35 of Septerna, Inc.6
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1SEC EDGARSepterna, Inc., Board member
- 2SEC EDGAROrganon & Co., Board member
- 3
- 4
- 5
- 6SEC EDGARForm 4 filed Mar 6, 2025